These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 31120420)
1. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors. Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M Elife; 2019 May; 8():. PubMed ID: 31120420 [TBL] [Abstract][Full Text] [Related]
2. A new class of multimerization selective inhibitors of HIV-1 integrase. Sharma A; Slaughter A; Jena N; Feng L; Kessl JJ; Fadel HJ; Malani N; Male F; Wu L; Poeschla E; Bushman FD; Fuchs JR; Kvaratskhelia M PLoS Pathog; 2014 May; 10(5):e1004171. PubMed ID: 24874515 [TBL] [Abstract][Full Text] [Related]
3. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors. Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903 [TBL] [Abstract][Full Text] [Related]
4. Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing. Hoyte AC; Jamin AV; Koneru PC; Kobe MJ; Larue RC; Fuchs JR; Engelman AN; Kvaratskhelia M J Biol Chem; 2017 Dec; 292(48):19814-19825. PubMed ID: 28972144 [TBL] [Abstract][Full Text] [Related]
5. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain. Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997 [TBL] [Abstract][Full Text] [Related]
6. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer. Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ J Biol Chem; 2021; 296():100363. PubMed ID: 33539919 [TBL] [Abstract][Full Text] [Related]
7. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor. Nakamura T; Nakamura T; Amano M; Miyakawa T; Yamagata Y; Matsuoka M; Nakata H J Virol; 2020 Sep; 94(19):. PubMed ID: 32611758 [TBL] [Abstract][Full Text] [Related]
8. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors. Sun J; Kessl JJ Viruses; 2024 Jan; 16(2):. PubMed ID: 38399977 [TBL] [Abstract][Full Text] [Related]
12. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome. van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705 [TBL] [Abstract][Full Text] [Related]
13. Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells. Madison MK; Lawson DQ; Elliott J; Ozantürk AN; Koneru PC; Townsend D; Errando M; Kvaratskhelia M; Kutluay SB J Virol; 2017 Sep; 91(17):. PubMed ID: 28615207 [TBL] [Abstract][Full Text] [Related]
14. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency. Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179 [TBL] [Abstract][Full Text] [Related]
15. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity. Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a Distinct Chemical and Mechanistic Class of Allosteric HIV-1 Integrase Inhibitors with Antiretroviral Activity. Burlein C; Wang C; Xu M; Bhatt T; Stahlhut M; Ou Y; Adam GC; Heath J; Klein DJ; Sanders J; Narayan K; Abeywickrema P; Heo MR; Carroll SS; Grobler JA; Sharma S; Diamond TL; Converso A; Krosky DJ ACS Chem Biol; 2017 Nov; 12(11):2858-2865. PubMed ID: 29024587 [TBL] [Abstract][Full Text] [Related]